-
2
-
-
0025043959
-
The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus
-
de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 1990;347:558-61.
-
(1990)
Nature
, vol.347
, pp. 558-561
-
-
De Thé, H.1
Chomienne, C.2
Lanotte, M.3
Degos, L.4
Dejean, A.5
-
3
-
-
0025089467
-
Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17
-
Borrow J, Goddard AD, Sheer D, Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990;249:1577-80.
-
(1990)
Science
, vol.249
, pp. 1577-1580
-
-
Borrow, J.1
Goddard, A.D.2
Sheer, D.3
Solomon, E.4
-
4
-
-
0030738403
-
All-trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: Long-term follow-up of the New York study
-
Soignet S, Fleischauer A, Polyak T, Heller G, Warrell RP Jr. All-trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study. Cancer Chemother Pharmacol 1997;40:Suppl:S25-S29.
-
(1997)
Cancer Chemother Pharmacol
, vol.40
, Issue.SUPPL.
-
-
Soignet, S.1
Fleischauer, A.2
Polyak, T.3
Heller, G.4
Warrell Jr., R.P.5
-
5
-
-
0027368561
-
Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia: Results of a multicenter randomized trial
-
Fenaux P, Le Deley MC, Castaigne S, et al. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia: results of a multicenter randomized trial. Blood 1993;82:3241-9.
-
(1993)
Blood
, vol.82
, pp. 3241-3249
-
-
Fenaux, P.1
Le Deley, M.C.2
Castaigne, S.3
-
6
-
-
0028999532
-
All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia
-
Degos L, Dombret H, Chomienne C, et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995;85:2643-53.
-
(1995)
Blood
, vol.85
, pp. 2643-2653
-
-
Degos, L.1
Dombret, H.2
Chomienne, C.3
-
7
-
-
0030825408
-
Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy
-
Mandelli F, Diverio D, Avvisati G, et al. Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood 1997;90:1014-21.
-
(1997)
Blood
, vol.90
, pp. 1014-1021
-
-
Mandelli, F.1
Diverio, D.2
Avvisati, G.3
-
8
-
-
0030923479
-
All-trans-retinoic acid in acute promyelocytic leukemia
-
Erratum, N Engl J Med 1997;337:1639
-
Tallman MS, Andersen JW, Schiffer CA, et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997;337:1021-8. [Erratum, N Engl J Med 1997;337:1639.]
-
(1997)
N Engl J Med
, vol.337
, pp. 1021-1028
-
-
Tallman, M.S.1
Andersen, J.W.2
Schiffer, C.A.3
-
9
-
-
0023752982
-
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
-
Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988;72:567-72.
-
(1988)
Blood
, vol.72
, pp. 567-572
-
-
Huang, M.E.1
Ye, Y.C.2
Chen, S.R.3
-
10
-
-
0025201879
-
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results
-
Castaigne S, Chomienne C, Daniel MT, et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990;76:1704-9.
-
(1990)
Blood
, vol.76
, pp. 1704-1709
-
-
Castaigne, S.1
Chomienne, C.2
Daniel, M.T.3
-
11
-
-
0025882306
-
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
-
Warrell RP Jr, Frankel SR, Miller WH Jr, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991;324:1385-93.
-
(1991)
N Engl J Med
, vol.324
, pp. 1385-1393
-
-
Warrell Jr., R.P.1
Frankel, S.R.2
Miller Jr., W.H.3
-
12
-
-
0000210796
-
Treatment of acute promyelocytic leukemia by Ailing-1 therapy with use of syndrome differentiation of traditional Chinese medicine
-
Sun HD, Ma L, Hu XC, Zhang TD. Treatment of acute promyelocytic leukemia by Ailing-1 therapy with use of syndrome differentiation of traditional Chinese medicine. Chin J Comb Trad Chin Med West Med 1992; 12:170-1.
-
(1992)
Chin J Comb Trad Chin Med West Med
, vol.12
, pp. 170-171
-
-
Sun, H.D.1
Ma, L.2
Hu, X.C.3
Zhang, T.D.4
-
13
-
-
0001837016
-
Arsenic trioxide treated 72 cases of acute promyelocytic leukemia
-
Zhang P, Wang SY, Hu XH. Arsenic trioxide treated 72 cases of acute promyelocytic leukemia. Chin J Hematol 1996;17:58-62.
-
(1996)
Chin J Hematol
, vol.17
, pp. 58-62
-
-
Zhang, P.1
Wang, S.Y.2
Hu, X.H.3
-
14
-
-
0030610687
-
3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients
-
3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997;89:3354-60.
-
(1997)
Blood
, vol.89
, pp. 3354-3360
-
-
Shen, Z.-X.1
Chen, G.-Q.2
Ni, J.-H.3
-
15
-
-
0010740572
-
3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RARα/PML proteins
-
3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RARα/PML proteins. Blood 1996;88:1052-61.
-
(1996)
Blood
, vol.88
, pp. 1052-1061
-
-
Chen, G.-Q.1
Zhu, J.2
Shi, X.-G.3
-
16
-
-
0038125071
-
Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines
-
König A, Wrazel L, Warrell RP Jr, et al. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood 1997; 90:562-70.
-
(1997)
Blood
, vol.90
, pp. 562-570
-
-
König, A.1
Wrazel, L.2
Warrell Jr., R.P.3
-
17
-
-
0030890942
-
Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia
-
Zhu J, Koken MHM, Quignon F, et al. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci U S A 1997;94:3978-83.
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, pp. 3978-3983
-
-
Zhu, J.1
Koken, M.H.M.2
Quignon, F.3
-
18
-
-
0000531696
-
Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells
-
Shao W, Fanelli M, Ferrara FF, et al. Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 1998;90:124-33.
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 124-133
-
-
Shao, W.1
Fanelli, M.2
Ferrara, F.F.3
-
19
-
-
0026559655
-
Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia
-
Miller WH Jr, Kakizuka A, Frankel SR, et al. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci U S A 1992;89:2694-8.
-
(1992)
Proc Natl Acad Sci U S A
, vol.89
, pp. 2694-2698
-
-
Miller Jr., W.H.1
Kakizuka, A.2
Frankel, S.R.3
-
20
-
-
0027237223
-
Detection of minimal residual disease in acute promyelocytic leukemia by reverse transcription polymerase chain reaction assay for the PML/RAR-α fusion mRNA
-
Miller WH Jr, Levine K, DeBlasio A, Frankel SR, Dmitrovsky E, Warrell RP Jr. Detection of minimal residual disease in acute promyelocytic leukemia by reverse transcription polymerase chain reaction assay for the PML/RAR-α fusion mRNA. Blood 1993;82:1689-94.
-
(1993)
Blood
, vol.82
, pp. 1689-1694
-
-
Miller Jr., W.H.1
Levine, K.2
DeBlasio, A.3
Frankel, S.R.4
Dmitrovsky, E.5
Warrell Jr., R.P.6
-
21
-
-
0026647140
-
The "retinoic acid syndrome" in acute promyelocytic leukemia
-
Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP Jr. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med 1992;117:292-6.
-
(1992)
Ann Intern Med
, vol.117
, pp. 292-296
-
-
Frankel, S.R.1
Eardley, A.2
Lauwers, G.3
Weiss, M.4
Warrell Jr., R.P.5
-
22
-
-
0027937940
-
Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PML/RAR-α isoform, and CD13 expression in patients treated with all-trans retinoic acid
-
Vahdat L, Maslak P, Miller WH Jr, et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PML/RAR-α isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 1994;84:3843-9.
-
(1994)
Blood
, vol.84
, pp. 3843-3849
-
-
Vahdat, L.1
Maslak, P.2
Miller Jr., W.H.3
-
23
-
-
0026446190
-
Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia
-
Lo Coco F, Diverio D, Pandolfi PP, et al. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia. Lancet 1992;340:1437-8.
-
(1992)
Lancet
, vol.340
, pp. 1437-1438
-
-
Lo Coco, F.1
Diverio, D.2
Pandolfi, P.P.3
-
24
-
-
0026645140
-
Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reaction
-
Biondi A, Rambaldi A, Pandolfi PP, et al. Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 1992;80:492-7.
-
(1992)
Blood
, vol.80
, pp. 492-497
-
-
Biondi, A.1
Rambaldi, A.2
Pandolfi, P.P.3
-
25
-
-
0030061520
-
Minimal residual disease detection in acute promyelocytic leukemia by reverse transcriptase PCR: Evaluation of PML-RARα and RARα-PML assessment in patients who ultimately relapse
-
Grimwade D, Howe K, Langabeer S, Burnett A, Goldstone A, Solomon E. Minimal residual disease detection in acute promyelocytic leukemia by reverse transcriptase PCR: evaluation of PML-RARα and RARα-PML assessment in patients who ultimately relapse. Leukemia 1998;10: 61-6.
-
(1998)
Leukemia
, vol.10
, pp. 61-66
-
-
Grimwade, D.1
Howe, K.2
Langabeer, S.3
Burnett, A.4
Goldstone, A.5
Solomon, E.6
-
26
-
-
0030009694
-
RT-PCR in acute promyelocytic leukemia: Second workshop of the European Retinoic Group, Paris, France, 17-18 December 1994
-
RT-PCR in acute promyelocytic leukemia: second workshop of the European Retinoic Group, Paris, France, 17-18 December 1994. Leukemia 1996;10:368-71.
-
(1996)
Leukemia
, vol.10
, pp. 368-371
-
-
-
27
-
-
0000184378
-
Response and toxicity associated with dose escalation of arsenic trioxide in the treatment of resistant acute promyelocytic leukemia
-
abstract
-
Westervelt P, Pollock J, Haug J, Ley TJ, DiPersio JF. Response and toxicity associated with dose escalation of arsenic trioxide in the treatment of resistant acute promyelocytic leukemia. Blood 1997;90:Suppl 1:249b. abstract.
-
(1997)
Blood
, vol.90
, Issue.1 SUPPL.
-
-
Westervelt, P.1
Pollock, J.2
Haug, J.3
Ley, T.J.4
DiPersio, J.F.5
-
28
-
-
0028179010
-
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
-
Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 1994;76:333-43.
-
(1994)
Cell
, vol.76
, pp. 333-343
-
-
Dyck, J.A.1
Maul, G.G.2
Miller Jr., W.H.3
Chen, J.D.4
Kakizuka, A.5
Evans, R.M.6
-
29
-
-
0032170898
-
Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML/RAR-α independent manner
-
Wang Z-G, Rivi R, Delva L, et al. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML/RAR-α independent manner. Blood 1998;92:1497-504.
-
(1998)
Blood
, vol.92
, pp. 1497-1504
-
-
Wang, Z.-G.1
Rivi, R.2
Delva, L.3
-
31
-
-
0000222658
-
Cytotoxicity of arsenic trioxide in cancer cell lines
-
abstract
-
Yang CH, Wang TY, Chen YC. Cytotoxicity of arsenic trioxide in cancer cell lines. Proc Am Assoc Cancer Res 1998;39:227. abstract.
-
(1998)
Proc Am Assoc Cancer Res
, vol.39
, pp. 227
-
-
Yang, C.H.1
Wang, T.Y.2
Chen, Y.C.3
-
33
-
-
0002202054
-
Arsenic as therapeutic agent in chronic myelogenous leukemia: Preliminary report
-
Forkner CE, Scott TFM. Arsenic as therapeutic agent in chronic myelogenous leukemia: preliminary report. JAMA 1931;97:3-5.
-
(1931)
JAMA
, vol.97
, pp. 3-5
-
-
Forkner, C.E.1
Scott, T.F.M.2
-
34
-
-
0027241137
-
Pharmacokinetic properties of the trypanocidal drug melarsoprol
-
Burri C, Blatz T, Giroud C, Doua F, Welker HA, Brun R. Pharmacokinetic properties of the trypanocidal drug melarsoprol. Chemotherapy 1993;39:225-34.
-
(1993)
Chemotherapy
, vol.39
, pp. 225-234
-
-
Burri, C.1
Blatz, T.2
Giroud, C.3
Doua, F.4
Welker, H.A.5
Brun, R.6
-
35
-
-
0025368635
-
Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells
-
Terstappen LWMM, Hollander Z, Meiners H, Loken MR. Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J Leukoc Biol 1990;48:138-48.
-
(1990)
J Leukoc Biol
, vol.48
, pp. 138-148
-
-
Terstappen, L.W.M.M.1
Hollander, Z.2
Meiners, H.3
Loken, M.R.4
-
36
-
-
0027525104
-
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme
-
Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993;75:641-52.
-
(1993)
Cell
, vol.75
, pp. 641-652
-
-
Yuan, J.1
Shaham, S.2
Ledoux, S.3
Ellis, H.M.4
Horvitz, H.R.5
-
37
-
-
0030931876
-
Caspases: The executioners of apoptosis
-
Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326:1-16.
-
(1997)
Biochem J
, vol.326
, pp. 1-16
-
-
Cohen, G.M.1
-
38
-
-
0030838164
-
The caspase family of cysteine proteases
-
Thornberry NA. The caspase family of cysteine proteases. Br Med Bull 1997;53:478-90.
-
(1997)
Br Med Bull
, vol.53
, pp. 478-490
-
-
Thornberry, N.A.1
-
39
-
-
0030701895
-
Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis
-
Martins LM, Mesner PW, Kottke TJ, et al. Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood 1997;90:4283-96.
-
(1997)
Blood
, vol.90
, pp. 4283-4296
-
-
Martins, L.M.1
Mesner, P.W.2
Kottke, T.J.3
-
40
-
-
0342941158
-
Granulocytic differentiation of HL-60 cells results in spontaneous apoptosis mediated by increased caspase expression
-
Watson RWG, Rotstein OD, Parodo J, Bitar R, Hackam D, Marshall JC. Granulocytic differentiation of HL-60 cells results in spontaneous apoptosis mediated by increased caspase expression. FEBS Lett 1997;412: 603-9.
-
(1997)
FEBS Lett
, vol.412
, pp. 603-609
-
-
Watson, R.W.G.1
Rotstein, O.D.2
Parodo, J.3
Bitar, R.4
Hackam, D.5
Marshall, J.C.6
-
41
-
-
0030799123
-
Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation
-
Piedrafita FJ, Pfahl M. Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation. Mol Cell Biol 1997;17:6348-58.
-
(1997)
Mol Cell Biol
, vol.17
, pp. 6348-6358
-
-
Piedrafita, F.J.1
Pfahl, M.2
-
42
-
-
0027500261
-
Arsenical-resistant trypanosomes lack an unusual adenosine transporter
-
Erratum, Nature 1993;361:374
-
Carter NS, Fairlamb AH. Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature 1993;361:173-6. [Erratum, Nature 1993;361:374.]
-
(1993)
Nature
, vol.361
, pp. 173-176
-
-
Carter, N.S.1
Fairlamb, A.H.2
-
43
-
-
0343867144
-
Efflux-mediated resistance to arsenicals in arsenic-resistant and -hypersensitive Chinese hamster cells
-
Wang Z, Dey S, Rosen BP, Rossman TG. Efflux-mediated resistance to arsenicals in arsenic-resistant and -hypersensitive Chinese hamster cells. Toxicol Appl Pharmacol 1996;137:112-9.
-
(1996)
Toxicol Appl Pharmacol
, vol.137
, pp. 112-119
-
-
Wang, Z.1
Dey, S.2
Rosen, B.P.3
Rossman, T.G.4
|